Croda International has entered into an agreement with the U.S. government in which the government will provide up to $75 million to expand the company’s U.S. manufacturing capacity of ingredients for lipid systems used in novel therapeutic drugs, such as mRNA vaccines. In line with the company’s strategy to “Empower biologics delivery,” Croda will also invest up to $58 million, bringing the total project investment to up to $133 million. The investment will be used to establish a...